BINDLEY WILLIAM E

SEC source: 0001193125-26-405496 · ownership.xml · derivative · entry 2

BINDLEY WILLIAM E · CIK 0000903539 · Director · 10% owner · Member of 10% Owner Group

10b5-1 filing: No plan indicated

Ownership: Indirect · By Bindley Capital Partners I, LLC

Disclosed balance after: 0

Underlying: Class A Common Stock · 6,100,175 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Pursuant to Guardian Pharmacy Services, Inc.'s (the "Issuer") Amended and Restated Certificate of Incorporation, the Reporting Person's shares of Class B common stock automatically converted into shares of the Issuer's Class A common stock, on a one-for-one basis, on September 27, 2026.

F1 · price: Pursuant to Guardian Pharmacy Services, Inc.'s (the "Issuer") Amended and Restated Certificate of Incorporation, the Reporting Person's shares of Class B common stock automatically converted into shares of the Issuer's Class A common stock, on a one-for-one basis, on September 27, 2026.

F1 · derivative.exercise_date: Pursuant to Guardian Pharmacy Services, Inc.'s (the "Issuer") Amended and Restated Certificate of Incorporation, the Reporting Person's shares of Class B common stock automatically converted into shares of the Issuer's Class A common stock, on a one-for-one basis, on September 27, 2026.

F1 · derivative.expiration_date: Pursuant to Guardian Pharmacy Services, Inc.'s (the "Issuer") Amended and Restated Certificate of Incorporation, the Reporting Person's shares of Class B common stock automatically converted into shares of the Issuer's Class A common stock, on a one-for-one basis, on September 27, 2026.

SEC source: 0001193125-26-405496 · ownership.xml · nonDerivative · entry 1

BINDLEY WILLIAM E · CIK 0000903539 · Director · 10% owner · Member of 10% Owner Group

10b5-1 filing: No plan indicated

Ownership: Indirect · By Bindley Capital Partners I, LLC

Disclosed balance after: 16,669,666

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Pursuant to Guardian Pharmacy Services, Inc.'s (the "Issuer") Amended and Restated Certificate of Incorporation, the Reporting Person's shares of Class B common stock automatically converted into shares of the Issuer's Class A common stock, on a one-for-one basis, on September 27, 2026.

SEC source: 0001193125-26-134497 · ownership.xml · derivative · entry 2

BINDLEY WILLIAM E · CIK 0000903539 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · By Bindley Capital Partners I, LLC

Disclosed balance after: 6,100,175

Underlying: Class A Common Stock · 6,100,175 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Pursuant to Guardian Pharmacy Services, Inc.'s (the "Issuer") Amended and Restated Certificate of Incorporation, the Reporting Person's shares of Class B common stock automatically convert into shares of the Issuer's Class A common stock, on a one-for-one basis, in substantially equal tranches on each of March 28, 2026 and September 27, 2026.

F1 · price: Pursuant to Guardian Pharmacy Services, Inc.'s (the "Issuer") Amended and Restated Certificate of Incorporation, the Reporting Person's shares of Class B common stock automatically convert into shares of the Issuer's Class A common stock, on a one-for-one basis, in substantially equal tranches on each of March 28, 2026 and September 27, 2026.

F1 · derivative.exercise_date: Pursuant to Guardian Pharmacy Services, Inc.'s (the "Issuer") Amended and Restated Certificate of Incorporation, the Reporting Person's shares of Class B common stock automatically convert into shares of the Issuer's Class A common stock, on a one-for-one basis, in substantially equal tranches on each of March 28, 2026 and September 27, 2026.

F1 · derivative.expiration_date: Pursuant to Guardian Pharmacy Services, Inc.'s (the "Issuer") Amended and Restated Certificate of Incorporation, the Reporting Person's shares of Class B common stock automatically convert into shares of the Issuer's Class A common stock, on a one-for-one basis, in substantially equal tranches on each of March 28, 2026 and September 27, 2026.

SEC source: 0001193125-26-134497 · ownership.xml · nonDerivative · entry 1

BINDLEY WILLIAM E · CIK 0000903539 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · By Bindley Capital Partners I, LLC

Disclosed balance after: 10,569,491

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Pursuant to Guardian Pharmacy Services, Inc.'s (the "Issuer") Amended and Restated Certificate of Incorporation, the Reporting Person's shares of Class B common stock automatically convert into shares of the Issuer's Class A common stock, on a one-for-one basis, in substantially equal tranches on each of March 28, 2026 and September 27, 2026.

SEC source: 0001193125-26-121838 · ownership.xml · nonDerivative · entry 1

BINDLEY WILLIAM E · CIK 0000903539 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · By Bindley Capital Partners I, LLC

Disclosed balance after: 4,469,316

F1 · kind: Represents shares of Class A common stock, par value $0.001 per share, of Guardian Pharmacy Services, Inc. (the "Issuer"), sold pursuant to the Underwriting Agreement, dated March 18, 2026, by and among the Issuer, the selling stockholders party thereto and BofA Securities, Inc. and Jefferies LLC, as representatives of the several underwriters named therein.

SEC source: 0001193125-25-225029 · ownership.xml · derivative · entry 2

BINDLEY WILLIAM E · CIK 0000903539 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · By Bindley Capital Partners I, LLC

Disclosed balance after: 12,200,350

Underlying: Class A Common Stock · 6,100,176 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Pursuant to Guardian Pharmacy Services, Inc.'s (the "Issuer") Amended and Restated Certificate of Incorporation, the Reporting Person's shares of Class B common stock automatically convert into shares of the Issuer's Class A common stock, on a one-for-one basis, in substantially equal tranches on each of September 27, 2025, March 28, 2026 and September 27, 2026.

F1 · price: Pursuant to Guardian Pharmacy Services, Inc.'s (the "Issuer") Amended and Restated Certificate of Incorporation, the Reporting Person's shares of Class B common stock automatically convert into shares of the Issuer's Class A common stock, on a one-for-one basis, in substantially equal tranches on each of September 27, 2025, March 28, 2026 and September 27, 2026.

F1 · derivative.exercise_date: Pursuant to Guardian Pharmacy Services, Inc.'s (the "Issuer") Amended and Restated Certificate of Incorporation, the Reporting Person's shares of Class B common stock automatically convert into shares of the Issuer's Class A common stock, on a one-for-one basis, in substantially equal tranches on each of September 27, 2025, March 28, 2026 and September 27, 2026.

F1 · derivative.expiration_date: Pursuant to Guardian Pharmacy Services, Inc.'s (the "Issuer") Amended and Restated Certificate of Incorporation, the Reporting Person's shares of Class B common stock automatically convert into shares of the Issuer's Class A common stock, on a one-for-one basis, in substantially equal tranches on each of September 27, 2025, March 28, 2026 and September 27, 2026.

SEC source: 0001193125-25-225029 · ownership.xml · nonDerivative · entry 1

BINDLEY WILLIAM E · CIK 0000903539 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · By Bindley Capital Partners I, LLC

Disclosed balance after: 8,039,993

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Pursuant to Guardian Pharmacy Services, Inc.'s (the "Issuer") Amended and Restated Certificate of Incorporation, the Reporting Person's shares of Class B common stock automatically convert into shares of the Issuer's Class A common stock, on a one-for-one basis, in substantially equal tranches on each of September 27, 2025, March 28, 2026 and September 27, 2026.

SEC source: 0000950170-25-078973 · ownership.xml · nonDerivative · entry 2

BINDLEY WILLIAM E · CIK 0000903539 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · By Bindley Capital Partners I, LLC

Disclosed balance after: 1,939,817

F1 · kind: Represents shares of Class A common stock, par value $0.001 per share, of Guardian Pharmacy Services, Inc. (the "Issuer"), sold pursuant to the Underwriting Agreement, dated May 22, 2025, by and among the Issuer, the selling stockholders party thereto and Raymond James & Associates, Inc., as representative of the several underwriters named therein.

SEC source: 0000950170-25-078973 · ownership.xml · nonDerivative · entry 1

BINDLEY WILLIAM E · CIK 0000903539 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · By Bindley Capital Partners I, LLC

Disclosed balance after: 2,591,271

F1 · kind: Represents shares of Class A common stock, par value $0.001 per share, of Guardian Pharmacy Services, Inc. (the "Issuer"), sold pursuant to the Underwriting Agreement, dated May 22, 2025, by and among the Issuer, the selling stockholders party thereto and Raymond James & Associates, Inc., as representative of the several underwriters named therein.

SEC source: 0000950170-25-048679 · ownership.xml · derivative · entry 2

BINDLEY WILLIAM E · CIK 0000903539 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · By Bindley Capital Partners I, LLC

Disclosed balance after: 18,300,526

Underlying: Class A Common Stock · 6,100,176 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Pursuant to Guardian Pharmacy Services, Inc.'s (the "Issuer") Amended and Restated Certificate of Incorporation, the Reporting Person's shares of Class B common stock automatically convert into shares of the Issuer's Class A common stock, on a one-for-one basis, in four substantially equal tranches on each of March 28, 2025, September 27, 2025, March 28, 2026 and September 27, 2026.

F1 · price: Pursuant to Guardian Pharmacy Services, Inc.'s (the "Issuer") Amended and Restated Certificate of Incorporation, the Reporting Person's shares of Class B common stock automatically convert into shares of the Issuer's Class A common stock, on a one-for-one basis, in four substantially equal tranches on each of March 28, 2025, September 27, 2025, March 28, 2026 and September 27, 2026.

F1 · derivative.exercise_date: Pursuant to Guardian Pharmacy Services, Inc.'s (the "Issuer") Amended and Restated Certificate of Incorporation, the Reporting Person's shares of Class B common stock automatically convert into shares of the Issuer's Class A common stock, on a one-for-one basis, in four substantially equal tranches on each of March 28, 2025, September 27, 2025, March 28, 2026 and September 27, 2026.

F1 · derivative.expiration_date: Pursuant to Guardian Pharmacy Services, Inc.'s (the "Issuer") Amended and Restated Certificate of Incorporation, the Reporting Person's shares of Class B common stock automatically convert into shares of the Issuer's Class A common stock, on a one-for-one basis, in four substantially equal tranches on each of March 28, 2025, September 27, 2025, March 28, 2026 and September 27, 2026.

SEC source: 0000950170-25-048679 · ownership.xml · nonDerivative · entry 1

BINDLEY WILLIAM E · CIK 0000903539 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · By Bindley Capital Partners I, LLC

Disclosed balance after: 6,100,176

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Pursuant to Guardian Pharmacy Services, Inc.'s (the "Issuer") Amended and Restated Certificate of Incorporation, the Reporting Person's shares of Class B common stock automatically convert into shares of the Issuer's Class A common stock, on a one-for-one basis, in four substantially equal tranches on each of March 28, 2025, September 27, 2025, March 28, 2026 and September 27, 2026.

SEC source: 0000950170-24-111018 · ownership.xml · derivative · entry 1

BINDLEY WILLIAM E · CIK 0000903539 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · By Bindley Capital Partners I, LLC

Disclosed balance after: 24,400,702

Underlying: Class A Common Stock · 24,400,702 shares

Expires not disclosed

F1 · security: Represents shares of Class B common stock issued pursuant to the Agreement and Plan of Merger, dated as of September 27, 2024 (the "Merger Agreement"), by and among Guardian Pharmacy Services, Inc. (the "Issuer"), Guardian Merger Corp., a wholly owned subsidiary of the Issuer ("Merger Sub"), and Guardian Pharmacy, LLC, providing for the merger of Merger Sub with and into Guardian Pharmacy, LLC. As a result of the merger and pursuant to the Merger Agreement, each issued and outstanding common unit of Guardian Pharmacy, LLC (other than common units held by Guardian Investor, Inc.) was converted into one share of Class B common stock and the right to receive $1.02 in cash. The shares of Class B common stock issued will automatically convert into shares of Class A common stock on a one-for-one basis in four equal tranches on each of March 28, 2025, September 27, 2025, March 28, 2026 and September 27, 2026.

F1 · derivative.exercise_price: Represents shares of Class B common stock issued pursuant to the Agreement and Plan of Merger, dated as of September 27, 2024 (the "Merger Agreement"), by and among Guardian Pharmacy Services, Inc. (the "Issuer"), Guardian Merger Corp., a wholly owned subsidiary of the Issuer ("Merger Sub"), and Guardian Pharmacy, LLC, providing for the merger of Merger Sub with and into Guardian Pharmacy, LLC. As a result of the merger and pursuant to the Merger Agreement, each issued and outstanding common unit of Guardian Pharmacy, LLC (other than common units held by Guardian Investor, Inc.) was converted into one share of Class B common stock and the right to receive $1.02 in cash. The shares of Class B common stock issued will automatically convert into shares of Class A common stock on a one-for-one basis in four equal tranches on each of March 28, 2025, September 27, 2025, March 28, 2026 and September 27, 2026.

F1 · price: Represents shares of Class B common stock issued pursuant to the Agreement and Plan of Merger, dated as of September 27, 2024 (the "Merger Agreement"), by and among Guardian Pharmacy Services, Inc. (the "Issuer"), Guardian Merger Corp., a wholly owned subsidiary of the Issuer ("Merger Sub"), and Guardian Pharmacy, LLC, providing for the merger of Merger Sub with and into Guardian Pharmacy, LLC. As a result of the merger and pursuant to the Merger Agreement, each issued and outstanding common unit of Guardian Pharmacy, LLC (other than common units held by Guardian Investor, Inc.) was converted into one share of Class B common stock and the right to receive $1.02 in cash. The shares of Class B common stock issued will automatically convert into shares of Class A common stock on a one-for-one basis in four equal tranches on each of March 28, 2025, September 27, 2025, March 28, 2026 and September 27, 2026.

F1 · derivative.exercise_date: Represents shares of Class B common stock issued pursuant to the Agreement and Plan of Merger, dated as of September 27, 2024 (the "Merger Agreement"), by and among Guardian Pharmacy Services, Inc. (the "Issuer"), Guardian Merger Corp., a wholly owned subsidiary of the Issuer ("Merger Sub"), and Guardian Pharmacy, LLC, providing for the merger of Merger Sub with and into Guardian Pharmacy, LLC. As a result of the merger and pursuant to the Merger Agreement, each issued and outstanding common unit of Guardian Pharmacy, LLC (other than common units held by Guardian Investor, Inc.) was converted into one share of Class B common stock and the right to receive $1.02 in cash. The shares of Class B common stock issued will automatically convert into shares of Class A common stock on a one-for-one basis in four equal tranches on each of March 28, 2025, September 27, 2025, March 28, 2026 and September 27, 2026.

F1 · derivative.expiration_date: Represents shares of Class B common stock issued pursuant to the Agreement and Plan of Merger, dated as of September 27, 2024 (the "Merger Agreement"), by and among Guardian Pharmacy Services, Inc. (the "Issuer"), Guardian Merger Corp., a wholly owned subsidiary of the Issuer ("Merger Sub"), and Guardian Pharmacy, LLC, providing for the merger of Merger Sub with and into Guardian Pharmacy, LLC. As a result of the merger and pursuant to the Merger Agreement, each issued and outstanding common unit of Guardian Pharmacy, LLC (other than common units held by Guardian Investor, Inc.) was converted into one share of Class B common stock and the right to receive $1.02 in cash. The shares of Class B common stock issued will automatically convert into shares of Class A common stock on a one-for-one basis in four equal tranches on each of March 28, 2025, September 27, 2025, March 28, 2026 and September 27, 2026.

SEC source: 0001286043-23-000062 · wk-form4_1683923725.xml · nonDerivative · entry 1

BINDLEY WILLIAM E · CIK 0000903539 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 207,147

SEC source: 0001286043-22-000069 · wf-form4_165247521836161.xml · nonDerivative · entry 1

BINDLEY WILLIAM E · CIK 0000903539 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 200,839

SEC source: 0001286043-21-000078 · wf-form4_162102322942578.xml · nonDerivative · entry 1

BINDLEY WILLIAM E · CIK 0000903539 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 194,345

SEC source: 0001286043-20-000090 · wf-form4_158983338546853.xml · nonDerivative · entry 1

BINDLEY WILLIAM E · CIK 0000903539 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 189,277

SEC source: 0001286043-19-000073 · wf-form4_155803900620674.xml · nonDerivative · entry 1

BINDLEY WILLIAM E · CIK 0000903539 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 176,992

SEC source: 0001286043-18-000071 · wf-form4_152598502748973.xml · nonDerivative · entry 1

BINDLEY WILLIAM E · CIK 0000903539 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 170,831

SEC source: 0001286043-18-000010 · wf-form4_151803881988972.xml · nonDerivative · entry 2

BINDLEY WILLIAM E · CIK 0000903539 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 163,934

F2 · price: This transaction was executed in multiple trades at prices ranging from $14.76 to $15.29. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001286043-18-000010 · wf-form4_151803881988972.xml · nonDerivative · entry 1

BINDLEY WILLIAM E · CIK 0000903539 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 85,014

F1 · price: This transaction was executed in multiple trades at prices ranging from $15.07 to $15.10. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001286043-17-000078 · wf-form4_149462229009001.xml · nonDerivative · entry 1

BINDLEY WILLIAM E · CIK 0000903539 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 63,362